Definition and nomenclature, Introduction and general description, Epidemiology, Pathophysiology

• 1  Darsow U, Lubbe J, Taieb A, et al. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2005;19(3):286–95. Cross Ref link Pubmed link
• 2  Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med 2005;352(22):2314–24. Cross Ref link Pubmed link
• 3  Brown S, Reynolds NJ. Atopic and non‐atopic eczema. BMJ 2006;332(7541):584–8. Cross Ref link Pubmed link
• 4  Juhlin L, Johansson GO, Bennich H, Hogman C, Thyresson N. Immunoglobulin E in dermatoses. Levels in atopic dermatitis and urticaria. Arch Dermatol 1969;100(1):12–16. Cross Ref link Pubmed link
• 5  Halbert AR, Weston WL, Morelli JG. Atopic dermatitis: is it an allergic disease? J Am Acad Dermatol 1995;33(6):1008–18. Cross Ref link Pubmed link
• 6  Schmid‐Grendelmeier P, Simon D, Simon HU, Akdis CA, Wuthrich B. Epidemiology, clinical features, and immunology of the “intrinsic” (non‐IgE‐mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 2001;56(9):841–9. Cross Ref link Pubmed link
• 7  Flohr C, Johansson SG, Wahlgren CF, Williams H. How atopic is atopic dermatitis? J Allergy Clin Immunol 2004;114(1):150–8. Cross Ref link Pubmed link
• 8  Park JH, Choi YL, Namkung JH, et al. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables. Br J Dermatol 2006;155(4):778–83. Cross Ref link Pubmed link
• 9  Folster‐Holst R, Pape M, Buss YL, Christophers E, Weichenthal M. Low prevalence of the intrinsic form of atopic dermatitis among adult patients. Allergy 2006;61(5):629–32. Cross Ref link Pubmed link
• 10  Johansson SG, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56(9):813–24. Cross Ref link Pubmed link
• 11  Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113(5):832–6. Cross Ref link Pubmed link
• 12  Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980;92:44–7.
• 13  Schultz Larsen F, Hanifin JM. Secular change in the occurrence of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:7–12. Pubmed link
• 14  Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994;131(3):406–16. Cross Ref link Pubmed link
• 15  Williams HC, Burney PG, Pembroke AC, Hay RJ. Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party. Br J Dermatol 1996;135(1):12–17. Cross Ref link Pubmed link
• 16  Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994;131(3):406–16. Cross Ref link Pubmed link
• 17  Bos JD, Van Leent EJ, Sillevis Smitt JH. The millennium criteria for the diagnosis of atopic dermatitis. Exp Dermatol 1998;7(4):132–8. Cross Ref link Pubmed link
• 18  Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 2003;49(6):1088–95. Cross Ref link Pubmed link
• 19  Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross‐sectional surveys. Lancet 2006;368(9537):733–43. Cross Ref link Pubmed link
• 20  Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, Group IPTS. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009;124(6):1251–8.e23. Cross Ref link Pubmed link
• 21  Flohr C, Williams HC. The epidemiology of atopic dermatitis. In: Irvine AD, Hoeger PH, Yan AC, eds. Harper's Textbook of Pediatric Dermatology, 4th edn. Oxford: Wiley‐Blackwell, 2011.
• 22  Williams HC. Epidemiology of atopic dermatitis: recent advances and future predictions. Curr Probl Dermatol 1999;28:9–17. Cross Ref link Pubmed link
• 23  Williams H, Stewart A, von Mutius E, et al. and International Study of Allergy.. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008;121(4):947–54 e15. Cross Ref link Pubmed link
• 24  Deckers IA, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A. Investigating international time trends in the incidence and prevalence of atopic eczema 1990–2010: a systematic review of epidemiological studies. PLOS One 2012;7(7):e39803. Cross Ref link Pubmed link
• 25  Saeki H, Tsunemi Y, Fujita H, et al. Prevalence of atopic dermatitis determined by clinical examination in Japanese adults. J Dermatol 2006;33(11):817–19. Cross Ref link Pubmed link
• 26  Harrop J, Chinn S, Verlato G, et al. Eczema, atopy and allergen exposure in adults: a population‐based study. Clin Exp Allergy 2007;37(4):526–35. Cross Ref link Pubmed link
• 27  Emerson RM, Williams HC, Allen BR. Severity distribution of atopic dermatitis in the community and its relationship to secondary referral. Br J Dermatol 1998;139(1):73–6. Cross Ref link Pubmed link
• 28  Ballardini N, Kull I, Soderhall C, Lilja G, Wickman M, Wahlgren CF. Eczema severity in preadolescent children and its relation to sex, filaggrin mutations, asthma, rhinitis, aggravating factors and topical treatment: a report from the BAMSE birth cohort. Br J Dermatol 2013;168(3):588–94. Cross Ref link Pubmed link
• 29  McAleer MA, Flohr C, Irvine AD. Management of difficult and severe eczema in childhood. BMJ 2012;345:e4770. Cross Ref link Pubmed link
• 30  Ballardini N, Kull I, Lind T, et al. Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort. Allergy 2012;67(4):537–44. Cross Ref link Pubmed link
• 31  Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014;134(6):1527–34. Cross Ref link Pubmed link
• 32  Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19(3):210–16. Cross Ref link Pubmed link
• 33  Schmitt J, Meurer M, Klon M, Frick KD. Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population‐based study. Br J Dermatol 2008;158(2):351–9. Cross Ref link Pubmed link
• 34  Ben‐Gashir MA, Seed PT, Hay RJ. Are quality of family life and disease severity related in childhood atopic dermatitis? J Eur Acad Dermatol Venereol 2002;16(5):455–62. Cross Ref link Pubmed link
• 35  McKenna SP, Doward LC, Meads DM, Tennant A, Lawton G, Grueger J. Quality of life in infants and children with atopic dermatitis: addressing issues of differential item functioning across countries in multinational clinical trials. Health Qual Life Outcomes 2007;5:45. Cross Ref link Pubmed link
• 36  Schmitt J, Chen CM, Apfelbacher C, et al. Infant eczema, infant sleeping problems, and mental health at 10 years of age: the prospective birth cohort study LISAplus. Allergy 2011;66(3):404–11. Cross Ref link Pubmed link
• 37  Suh D‐C, Sung J, Gause D, Raut M, Huang J, Choi I‐S. Economic burden of atopic manifestations in patients with atopic dermatitis – analysis of administrative claims. J Manage Care Pharm 2007;13(9):778–89.
• 38  Flohr C. Recent perspectives on the global epidemiology of childhood eczema. Allergol Immunopathol (Madr) 2011;39(3):174–82. Cross Ref link Pubmed link
• 39  Schafer T, Kramer U, Vieluf D, Abeck D, Behrendt H, Ring J. The excess of atopic eczema in East Germany is related to the intrinsic type. Br J Dermatol 2000;143(5):992–8. Cross Ref link Pubmed link
• 40  Burrel‐Morris C, Williams HC. Atopic dermatitis in migrant populations. In: Williams HC, ed. Atopic Dermatitis: The epidemiology, causes and prevention of atopic eczema. Cambridge: Cambridge University Press, 2000:169–82. Cross Ref link
• 41  Cramer C, Link E, Koletzko S, et al. The hygiene hypothesis does not apply to atopic eczema in childhood. Chem Immunol Allergy 2012;96:15–23. Cross Ref link Pubmed link
• 42  Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007;120(1):150–5. Cross Ref link Pubmed link
• 43  Schultz Larsen FV, Holm NV. Atopic dermatitis in a population based twin series. Concordance rates and heritability estimation. Acta Derm Venereol Suppl (Stockh) 1985;114:159. Pubmed link
• 44  Larsen FS, Holm NV, Henningsen K. Atopic dermatitis. A genetic–epidemiologic study in a population‐based twin sample. J Am Acad Dermatol 1986;15(3):487–94. Cross Ref link Pubmed link
• 45  Schultz Larsen F. The epidemiology of atopic dermatitis. Monogr Allergy 1993;31:9–28. Pubmed link
• 46  Lee YA, Wahn U, Kehrt R, et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 2000;26(4):470–3. Cross Ref link Pubmed link
• 47  Cookson WO, Ubhi B, Lawrence R, et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 2001;27(4):372–3. Cross Ref link Pubmed link
• 48  Bradley M, Soderhall C, Luthman H, Wahlgren CF, Kockum I, Nordenskjold M. Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population. Hum Mol Genet 2002;11(13):1539–48. Cross Ref link Pubmed link
• 49  Haagerup A, Bjerke T, Schiotz PO, et al. Atopic dermatitis – a total genome‐scan for susceptibility genes. Acta Derm Venereol 2004;84(5):346–52. Cross Ref link Pubmed link
• 50  Enomoto H, Noguchi E, Iijima S, et al. Single nucleotide polymorphism‐based genome‐wide linkage analysis in Japanese atopic dermatitis families. BMC Dermatol 2007;7:5. Cross Ref link Pubmed link
• 51  Guilloud‐Bataille M, Bouzigon E, Annesi‐Maesano I, et al. Evidence for linkage of a new region (11p14) to eczema and allergic diseases. Hum Genet 2008;122(6):605–14. Cross Ref link Pubmed link
• 52  Hirota T, Takahashi A, Kubo M, et al. Genome‐wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population. Nat Genet 2012;44(11):1222–6. Cross Ref link Pubmed link
• 53  Sun LD, Xiao FL, Li Y, et al. Genome‐wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population. Nat Genet 2011;43(7):690–4. Cross Ref link Pubmed link
• 54  Weidinger S, Willis‐Owen SA, Kamatani Y, et al. A genome‐wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet 2013 Dec 1;22(23):4841–56. Cross Ref link Pubmed link
• 55  Paternoster L, Standl M, Chen CM, et al. Meta‐analysis of genome‐wide association studies identifies three new risk loci for atopic dermatitis. Nat Genet 2011;44(2):187–92. Cross Ref link Pubmed link
• 56  Esparza‐Gordillo J, Weidinger S, Folster‐Holst R, et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet 2009;41(5):596–601. Cross Ref link Pubmed link
• 57  Farh KK, Marson A, Zhu J, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 2015 Feb 19;518(7539):337–43. Cross Ref link Pubmed link
• 58  Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol 2010;125(1):16–29 e1–11; quiz 30–1. Cross Ref link Pubmed link
• 59  Sherriff A, Golding J, Alspac Study T. Hygiene levels in a contemporary population cohort are associated with wheezing and atopic eczema in preschool infants. Arch Dis Child 2002;87(1):26–9. Cross Ref link Pubmed link
• 60  McNally NJ, Williams HC, Phillips DR, et al. Atopic eczema and domestic water hardness. Lancet 1998;352(9127):527–31. Cross Ref link Pubmed link
• 61  Cork MJ, Robinson DA, Vasilopoulos Y, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene–environment interactions. J Allergy Clin Immunol 2006;118(1):3–21; quiz 2–3. Cross Ref link Pubmed link
• 62  Proksch E, Folster‐Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 2006;43(3):159–69. Cross Ref link Pubmed link
• 63  Jakasa I, de Jongh CM, Verberk MM, Bos JD, Kezic S. Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects. Br J Dermatol 2006;155(1):104–9. Cross Ref link Pubmed link
• 64  Nemoto‐Hasebe I, Akiyama M, Nomura T, Sandilands A, McLean WH, Shimizu H. Clinical severity correlates with impaired barrier in filaggrin‐related eczema. J Invest Dermatol 2009;129(3):682–9. Cross Ref link Pubmed link
• 65  Palmer CN, Irvine AD, Terron‐Kwiatkowski A, et al. Common loss‐of‐function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38(4):441–6. Cross Ref link Pubmed link
• 66  McAleer MA, Irvine AD. The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol 2013;131(2):280–91. Cross Ref link Pubmed link
• 67  Walley AJ, Chavanas S, Moffatt MF, et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001;29(2):175–8. Cross Ref link Pubmed link
• 68  Kato A, Fukai K, Oiso N, Hosomi N, Murakami T, Ishii M. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol 2003;148(4):665–9. Cross Ref link Pubmed link
• 69  Nishio Y, Noguchi E, Shibasaki M, et al. Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese. Genes Immun 2003;4(7):515–17. Cross Ref link Pubmed link
• 70  Brown SJ, McLean WH. One remarkable molecule: filaggrin. J Invest Dermatol 2012;132(3 Pt 2):751–62. Cross Ref link Pubmed link
• 71  Brown SJ, Sandilands A, Zhao Y, et al. Prevalent and low‐frequency null mutations in the filaggrin gene are associated with early‐onset and persistent atopic eczema. J Invest Dermatol 2008;128(6):1591–4. Cross Ref link Pubmed link
• 72  Rodriguez E, Baurecht H, Herberich E, et al. Meta‐analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009;123(6):1361–70 e7. Cross Ref link Pubmed link
• 73  van den Oord RA, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta‐analysis. BMJ 2009;339:b2433. Cross Ref link Pubmed link
• 74  Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011;365(14):1315–27. Cross Ref link Pubmed link
• 75  Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011;242(1):233–46. Cross Ref link Pubmed link
• 76  Marenholz I, Kerscher T, Bauerfeind A, et al. An interaction between filaggrin mutations and early food sensitization improves the prediction of childhood asthma. J Allergy Clin Immunol 2009;123(4):911–16. Cross Ref link Pubmed link
• 77  Gao PS, Rafaels NM, Hand T, et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol 2009;124(3):507–13, 13 e1–7. Cross Ref link Pubmed link
• 78  Howell MD, Fairchild HR, Kim BE, et al. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008;128(9):2248–58. Cross Ref link Pubmed link
• 79  Kirschner N, Rosenthal R, Furuse M, Moll I, Fromm M, Brandner JM. Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes. J Invest Dermatol 2013;133(5):1161–9. Cross Ref link Pubmed link
• 80  De Benedetto A, Rafaels NM, McGirt LY, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 2011;127(3):773–86 e1–7. Cross Ref link Pubmed link
• 81  van den Bogaard EH, Bergboer JG, Vonk‐Bergers M, et al. Coal tar induces AHR‐dependent skin barrier repair in atopic dermatitis. J Clin Invest 2013;123(2):917–27. Pubmed link
• 82  Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol 2009;9(5):437–46. Cross Ref link Pubmed link
• 83  Weiland SK, Husing A, Strachan DP, Rzehak P, Pearce N, Group IPOS. Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children. Occup Environ Med 2004;61(7):609–15. Cross Ref link Pubmed link
• 84  Suarez‐Varela MM, Garcia‐Marcos Alvarez L, et al. Climate and prevalence of atopic eczema in 6‐ to 7‐year‐old school children in Spain. ISAAC phase III. Int J Biometeorol 2008;52(8):833–40. Cross Ref link Pubmed link
• 85  Lee YL, Su HJ, Sheu HM, Yu HS, Guo YL. Traffic‐related air pollution, climate, and prevalence of eczema in Taiwanese school children. J Invest Dermatol 2008;128(10):2412–20. Cross Ref link Pubmed link
• 86  Silverberg JI, Hanifin J, Simpson EL. Climatic factors are associated with childhood eczema prevalence in the United States. J Invest Dermatol 2013 Jul;133(7):1752–9. Cross Ref link Pubmed link
• 87  Byremo G, Rod G, Carlsen KH. Effect of climatic change in children with atopic eczema. Allergy 2006;61(12):1403–10. Cross Ref link Pubmed link
• 88  Miajlovic H, Fallon PG, Irvine AD, Foster TJ. Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol 2010;126(6):1184–90 e3. Cross Ref link Pubmed link
• 89  Langan SM, Silcocks P, Williams HC. What causes flares of eczema in children? Br J Dermatol 2009;161(3):640–6. Cross Ref link Pubmed link
• 90  Langan SM. Flares in childhood eczema. Skin Therapy Lett 2009;14(8):4–5. Pubmed link
• 91  Kramer U, Weidinger S, Darsow U, Mohrenschlager M, Ring J, Behrendt H. Seasonality in symptom severity influenced by temperature or grass pollen: results of a panel study in children with eczema. J Invest Dermatol 2005;124(3):514–23. Cross Ref link Pubmed link
• 92  Hugg T, Ruotsalainen R, Jaakkola MS, Pushkarev V, Jaakkola JJK. Comparison of allergic diseases, symptoms and respiratory infections between Finnish and Russian school children. Eur J Epidemiol 2008;23(2):123–33. Cross Ref link Pubmed link
• 93  Schram ME, Tedja AM, Spijker R, Bos JD, Williams HC, Spuls PI. Is there a rural/urban gradient in the prevalence of eczema? A systematic review. Br J Dermatol 2010;162(5):964–73. Cross Ref link Pubmed link
• 94  Ellwood P, Asher MI, Garcia‐Marcos L, et al. Do fast foods cause asthma, rhinoconjunctivitis and eczema? Global findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Thorax 2013;68(4):351–60. Cross Ref link Pubmed link
• 95  Ellwood P, Asher MI, Bjorksten B, Burr M, Pearce N, Robertson CF. Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group. Eur Resp J 2001;17(3):436–43. Cross Ref link
• 96  Sausenthaler S, Koletzko S, Schaaf B, et al. Maternal diet during pregnancy in relation to eczema and allergic sensitization in the offspring at 2 y of age. Am J Clin Nutr 2007;85(2):530–7. Pubmed link
• 97  Romieu I, Torrent M, Garcia‐Esteban R, et al. Maternal fish intake during pregnancy and atopy and asthma in infancy. Clin Exp Allergy 2007;37(4):518–25. Cross Ref link Pubmed link
• 98  Oien T, Storro O, Johnsen R. Do early intake of fish and fish oil protect against eczema and doctor‐diagnosed asthma at 2 years of age? A cohort study. J Epidemiol Community Health 2010;64(2):124–9. Cross Ref link Pubmed link
• 99  Alm B, Aberg N, Erdes L, Mollborg P, et al. Early introduction of fish decreases the risk of eczema in infants. Arch Dis Child 2009;94(1):11–15. Cross Ref link Pubmed link
• 100  Sausenthaler S, Kompauer I, Borte M, et al. Margarine and butter consumption, eczema and allergic sensitization in children. The LISA birth cohort study. Pediatr Allergy Immunol 2006;17(2):85–93. Cross Ref link Pubmed link
• 101  Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database Syst Rev 2012;9:CD000133. Pubmed link
• 102  Flohr C, Nagel G, Weinmayr G, et al. Lack of evidence for a protective effect of prolonged breastfeeding on childhood eczema: lessons from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol 2011;165(6):1280–9. Cross Ref link Pubmed link
• 103  Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst Rev 2012;8:CD003517. Pubmed link
• 104  Yao T‐C, Ou L‐S, Yeh K‐W, et al. Associations of age, gender, and BMI with prevalence of allergic diseases in children: PATCH study. J Asthma 2011;48(5):503–10. Cross Ref link Pubmed link
• 105  Silverberg JI, Kleiman E, Lev‐Tov H, et al. Association between obesity and atopic dermatitis in childhood: a case–control study. J Allergy Clin Immunol 2011;127(5):1180–6 e1. Cross Ref link Pubmed link
• 106  Murray CS, Canoy D, Buchan I, Woodcock A, Simpson A, Custovic A. Body mass index in young children and allergic disease: gender differences in a longitudinal study. Clin Exp Allergy 2011;41(1):78–85. Cross Ref link Pubmed link
• 107  Vlaski E, Stavric K, Isjanovska R, Seckova L, Kimovska M. Overweight hypothesis in asthma and eczema in young adolescents. Allergol Immunopathol (Madr) 2006;34(5):199–205. Cross Ref link Pubmed link
• 108  del Rio‐Navarro BE, Velazquez‐Monroy O, Sanchez‐Castillo CP, et al. The high prevalence of overweight and obesity in Mexican children. Obesity Res 2004;12(2):215–23. Cross Ref link
• 109  Mitchell EA, Beasley R, Bjorksten B, et al. The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy 2013;43(1):73–84. Cross Ref link Pubmed link
• 110  Morgenstern V, Zutavern A, Cyrys J, et al. Atopic diseases, allergic sensitization, and exposure to traffic‐related air pollution in children. Am J Respir Crit Care Med 2008;177(12):1331–7. Cross Ref link Pubmed link
• 111  Annesi‐Maesano I, Moreau D, Caillaud D, et al. Residential proximity fine particles related to allergic sensitisation and asthma in primary school children. Respir Med 2007;101(8):1721–9. Cross Ref link Pubmed link
• 112  Kramer U, Sugiri D, Ranft U, et al. Eczema, respiratory allergies, and traffic‐related air pollution in birth cohorts from small‐town areas. J Dermatol Sci 2009;56(2):99–105. Cross Ref link Pubmed link
• 113  Tanaka K, Miyake Y, Sasaki S, et al. Maternal smoking and environmental tobacco smoke exposure and the risk of allergic diseases in Japanese infants: the Osaka Maternal and Child Health Study. J Asthma 2008;45(9):833–8. Cross Ref link Pubmed link
• 114  Wichmann J, Wolvaardt JE, Maritz C, Voyi KVV. Household conditions, eczema symptoms and rhinitis symptoms: relationship with wheeze and severe wheeze in children living in the Polokwane area, South Africa. Matern Child Health J 2009;13(1):107–18. Cross Ref link Pubmed link
• 115  Lee YL, Li CW, Sung FC, Yu HS, Sheu HM, Guo YL. Environmental factors, parental atopy and atopic eczema in primary‐school children: a cross‐sectional study in Taiwan. Br J Dermatol 2007;157(6):1217–24. Cross Ref link Pubmed link
• 116  Jedrychowski W, Spengler JD, Maugeri U, et al. Effect of prenatal exposure to fine particulate matter and intake of Paracetamol (Acetaminophen) in pregnancy on eczema occurrence in early childhood. Sci Total Environ 2011;409(24):5205–9. Cross Ref link Pubmed link
• 117  Sariachvili M, Droste J, Dom S, et al. Is breast feeding a risk factor for eczema during the first year of life? Pediatr Allergy Immunol 2007;18(5):410–17. Cross Ref link Pubmed link
• 118  Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;299(6710):1259–60. Cross Ref link Pubmed link
• 119  Karmaus W, Botezan C. Does a higher number of siblings protect against the development of allergy and asthma? A review. J Epidemiol Community Health 2002;56(3):209–17. Cross Ref link Pubmed link
• 120  Apfelbacher CJ, Diepgen TL, Schmitt J. Determinants of eczema: population‐based cross‐sectional study in Germany. Allergy 2011;66(2):206–13. Cross Ref link Pubmed link
• 121  Cramer C, Link E, Horster M, et al. Elder siblings enhance the effect of filaggrin mutations on childhood eczema: results from the 2 birth cohort studies LISAplus and GINIplus. J Allergy Clin Immunol 2010;125(6):1254–60.e5. Cross Ref link Pubmed link
• 122  Hughes AM, Crouch S, Lightfoot T, Ansell P, Simpson J, Roman E. Eczema, birth order, and infection. Am J Epidemiol 2008;167(10):1182–7. Cross Ref link Pubmed link
• 123  Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the ‘hygiene hypothesis’: too clean to be true? Br J Dermatol 2005;152(2):202–16. Cross Ref link Pubmed link
• 124  Flohr C, Yeo L. Atopic dermatitis and the hygiene hypothesis revisited. Curr Prob Dermatol 2011;41:1–34. Cross Ref link
• 125  Miyake Y, Ohya Y, Tanaka K, et al. Home environment and suspected atopic eczema in Japanese infants: the Osaka Maternal and Child Health Study. Pediatr Allergy Immunol 2007;18(5):425–32. Cross Ref link Pubmed link
• 126  Celedon JC, Wright RJ, Litonjua AA, et al. Day care attendance in early life, maternal history of asthma, and asthma at the age of 6 years. Am J Respir Crit Care Med 2003;167(9):1239–43. Cross Ref link Pubmed link
• 127  Benn CS, Melbye M, Wohlfahrt J, Bjorksten B, Aaby P. Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. BMJ 2004;328(7450):1223. Cross Ref link Pubmed link
• 128  Dom S, Droste JH, Sariachvili MA, et al. Pre‐ and post‐natal exposure to antibiotics and the development of eczema, recurrent wheezing and atopic sensitization in children up to the age of 4 years. Clin Exp Allergy 2010;40(9):1378–87. Cross Ref link Pubmed link
• 129  Hagerhed‐Engman L, Bornehag CG, Sundell J, Aberg N. Day‐care attendance and increased risk for respiratory and allergic symptoms in preschool age. Allergy 2006;61(4):447–53. Cross Ref link Pubmed link
• 130  Cramer C, Link E, Bauer CP, et al. Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus. Allergy 2011;66(1):68–75. Cross Ref link Pubmed link
• 131  Braun‐Fahrlander C, Gassner M, Grize L, et al. Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community. SCARPOL team. Swiss Study on Childhood Allergy and Respiratory Symptoms with Respect to Air Pollution. Clin Exp Allergy 1999;29(1):28–34. Cross Ref link Pubmed link
• 132  Riedler J, Eder W, Oberfeld G, Schreuer M. Austrian children living on a farm have less hay fever, asthma and allergic sensitization. Clin Exp Allergy 2000;30(2):194–200. Cross Ref link Pubmed link
• 133  Kilpelainen M, Terho EO, Helenius H, Koskenvuo M. Farm environment in childhood prevents the development of allergies. Clin Exp Allergy 2000;30(2):201–8. Cross Ref link Pubmed link
• 134  Wickens K, Lane JM, Fitzharris P, et al. Farm residence and exposures and the risk of allergic diseases in New Zealand children. Allergy 2002;57(12):1171–9. Cross Ref link Pubmed link
• 135  Perkin MR, Strachan DP. Which aspects of the farming lifestyle explain the inverse association with childhood allergy? J Allergy Clin Immunol 2006;117(6):1374–81. Cross Ref link Pubmed link
• 136  Douwes J, Travier N, Huang K, et al. Lifelong farm exposure may strongly reduce the risk of asthma in adults. Allergy 2007;62(10):1158–65. Cross Ref link Pubmed link
• 137  Loss G, Apprich S, Waser M, et al. The protective effect of farm milk consumption on childhood asthma and atopy: the GABRIELA study. J Allergy Clin Immunol 2011;128(4):766–73 e4. Cross Ref link Pubmed link
• 138  Waser M, Michels KB, Bieli C, et al. Inverse association of farm milk consumption with asthma and allergy in rural and suburban populations across Europe. Clin Exp Allergy 2007;37(5):661–70. Cross Ref link Pubmed link
• 139  von Mutius E. Maternal farm exposure/ingestion of unpasteurized cow's milk and allergic disease. Curr Opin Gastroenterol 2012;28(6):570–6. Cross Ref link Pubmed link
• 140  Douwes J, Cheng S, Travier N, et al. Farm exposure in utero may protect against asthma, hay fever and eczema. Eur Resp J 2008;32(3):603–11. Cross Ref link
• 141  Roduit C, Wohlgensinger J, Frei R, et al. Prenatal animal contact and gene expression of innate immunity receptors at birth are associated with atopic dermatitis. J Allergy Clin Immunol 2011;127(1):179–85, 85 e1. Cross Ref link Pubmed link
• 142  Langan SM, Flohr C, Williams HC. The role of furry pets in eczema: a systematic review. Arch Dermatol 2007;143(12):1570–7. Cross Ref link Pubmed link
• 143  Bisgaard H, Simpson A, Palmer CNA, et al. Gene–environment interaction in the onset of eczema in infancy: filaggrin loss‐of‐function mutations enhanced by neonatal cat exposure. PLOS Med 2008;5(6):e131. Cross Ref link Pubmed link
• 144  Schuttelaar MLA, Kerkhof M, Jonkman MF, et al. Filaggrin mutations in the onset of eczema, sensitization, asthma, hay fever and the interaction with cat exposure. Allergy 2009;64(12):1758–65. Cross Ref link Pubmed link
• 145  Epstein TG, Bernstein DI, Levin L, et al. Opposing effects of cat and dog ownership and allergic sensitization on eczema in an atopic birth cohort. J Pediatr 2011;158(2):265–71.e1–5. Cross Ref link Pubmed link
• 146  Okada H, Kuhn C, Feillet H, Bach JF. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update. Clin Exp Immunol 2010;160(1):1–9. Cross Ref link Pubmed link
• 147  Flohr C, Quinnell RJ, Britton J. Do helminth parasites protect against atopy and allergic disease? Clin Exp Allergy 2009;39(1):20–32. Cross Ref link Pubmed link
• 148  Mpairwe H, Webb EL, Muhangi L, et al. Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised‐controlled trial results. Pediatr Allergy Immunol 2011;22(3):305–12. Cross Ref link Pubmed link
• 149  Cooper PJ, Chico ME, Vaca MG, et al. Effect of albendazole treatments on the prevalence of atopy in children living in communities endemic for geohelminth parasites: a cluster‐randomised trial. Lancet 2006;367(9522):1598–603. Cross Ref link Pubmed link
• 150  Flohr C, Tuyen LN, Quinnell RJ, et al. Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double‐blind, placebo‐controlled trial in Vietnam. Clin Exp Allergy 2010;40(1):131–42. Pubmed link
• 151  McKeever TM, Lewis SA, Smith C, Hubbard R. The importance of prenatal exposures on the development of allergic disease: a birth cohort study using the West Midlands General Practice Database. Am J Respir Crit Care Med 2002;166(6):827–32. Cross Ref link Pubmed link
• 152  Zutavern A, von Klot S, Gehring U, Krauss‐Etschmann S, Heinrich J. Pre‐natal and post‐natal exposure to respiratory infection and atopic diseases development: a historical cohort study. Respir Res 2006;7:81. Cross Ref link Pubmed link
• 153  Schmitt J, Schmitt NM, Kirch W, Meurer M. Early exposure to antibiotics and infections and the incidence of atopic eczema: a population‐based cohort study. Pediatr Allergy Immunol 2010;21(2 Pt 1):292–300. Cross Ref link Pubmed link
• 154  Tsakok T, McKeever TM, Yeo L, Flohr C. Does early life exposure to antibiotics increase the risk of eczema? A systematic review. Br J Dermatol 2013 Nov;169(5):983–91. Cross Ref link Pubmed link
• 155  Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2‐year‐old children. Clin Exp Allergy 1999;29(3):342–6. Cross Ref link Pubmed link
• 156  Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol 2011;9(4):244–53. Cross Ref link Pubmed link
• 157  Bieber T. Atopic dermatitis. N Engl J Med 2008;358(14):1483–94. Cross Ref link Pubmed link
• 158  Naik S, Bouladoux N, Wilhelm C, et al. Compartmentalized control of skin immunity by resident commensals. Science 2012;337(6098):1115–19. Cross Ref link Pubmed link
• 159  Wang M, Karlsson C, Olsson C, et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol 2008;121(1):129–34. Cross Ref link Pubmed link
• 160  Newell L, Polak ME, Perera J, et al. Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis. J Invest Dermatol 2013;133(10):2372–80. Cross Ref link Pubmed link
• 161  Koga C, Kabashima K, Shiraishi N, Kobayashi M, Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008;128(11):2625–30. Cross Ref link Pubmed link
• 162  Maggi L, Santarlasci V, Liotta F, et al. Demonstration of circulating allergen‐specific CD4(+)CD25(high)Foxp3(+) T‐regulatory cells in both nonatopic and atopic individuals. J Allergy Clin Immunol 2007;120(2):429–36. Cross Ref link Pubmed link
• 163  Schneider L, Weinberg A, Boguniewicz M, et al. Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controls. J Allergy Clin Immunol 2010;126(6):1306–7 e2. Cross Ref link Pubmed link
• 164  Grewe M, Walther S, Gyufko K, Czech W, Schopf E, Krutmann J. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 1995;105(3):407–10. Cross Ref link Pubmed link
• 165  Thepen T, Langeveld‐Wildschut EG, Bihari IC, et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996;97(3):828–37. Cross Ref link Pubmed link
• 166  Zachary CB, Poulter LW, MacDonald DM. Cell‐mediated immune responses in atopic dermatitis: the relevance of antigen‐presenting cells. Br J Dermatol 1985;113 Suppl. 28:10–16. Cross Ref link Pubmed link
• 167  Lever R, Turbitt M, Sanderson A, MacKie R. Immunophenotyping of the cutaneous infiltrate and of the mononuclear cells in the peripheral blood in patients with atopic dermatitis. J Invest Dermatol 1987;89(1):4–7. Cross Ref link Pubmed link
• 168  Bos JD, Hagenaars C, Das PK, Krieg SR, Voorn WJ, Kapsenberg ML. Predominance of “memory” T cells (CD4+, CDw29+) over “naive” T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch Dermatol Res 1989;281(1):24–30. Cross Ref link Pubmed link
• 169  Leung DY, Bhan AK, Schneeberger EE, Geha RS. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 1983;71(1 Pt 1):47–56. Cross Ref link Pubmed link
• 170  Piletta PA, Wirth S, Hommel L, Saurat JH, Hauser C. Circulating skin‐homing T cells in atopic dermatitis. Selective up‐regulation of HLA‐DR, interleukin‐2R, and CD30 and decrease after combined UV‐A and UV‐B phototherapy. Arch Dermatol 1996;132(10):1171–6. Cross Ref link Pubmed link
• 171  Wierenga EA, Snoek M, de Groot C, et al. Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol 1990;144(12):4651–6. Pubmed link
• 172  Parronchi P, Macchia D, Piccinni MP, et al. Allergen‐ and bacterial antigen‐specific T‐cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci U S A 1991;88(10):4538–42. Cross Ref link Pubmed link
• 173  Ardern‐Jones MR, Black AP, Bateman EA, Ogg GS. Bacterial superantigen facilitates epithelial presentation of allergen to T helper 2 cells. Proc Natl Acad Sci U S A 2007;104(13):5557–62. Cross Ref link Pubmed link
• 174  Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin‐5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87(5):1541–6. Cross Ref link Pubmed link
• 175  van der Heijden FL, Wierenga EA, Bos JD, Kapsenberg ML. High frequency of IL‐4‐producing CD4 +allergen‐specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991;97(3):389–94. Cross Ref link Pubmed link
• 176  Del Prete GF, De Carli M, D'Elios MM, et al. Allergen exposure induces the activation of allergen‐specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993;23(7):1445–9. Cross Ref link Pubmed link
• 177  Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178(6):2123–30. Cross Ref link Pubmed link
• 178  Varney VA, Hamid QA, Gaga M, et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen‐induced late‐phase cutaneous responses. J Clin Invest 1993;92(2):644–51. Cross Ref link Pubmed link
• 179  Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease of IL‐4 and IL‐5 and increase of IFN‐gamma secretion in specific allergen‐stimulated T cell cultures. J Immunol 1995;154(8):4187–94. Pubmed link
• 180  Agosti JM, Sprenger JD, Lum LG, et al. Transfer of allergen‐specific IgE‐mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med 1988;319(25):1623–8. Cross Ref link Pubmed link
• 181  Saurat JH. Eczema in primary immune‐deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott–Aldrich syndrome. Acta Derm Venereol Suppl (Stockh) 1985;114:125–8. Pubmed link
• 182  Koharazawa H, Kanamori H, Takabayashi M, et al. Resolution of atopic dermatitis following allogeneic bone marrow transplantation for chronic myelogenous leukemia. Bone Marrow Transpl 2005;35(12):1223–4. Cross Ref link
• 183  Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94(2):870–6. Cross Ref link Pubmed link
• 184  Nomura I, Goleva E, Howell MD, et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003;171(6):3262–9. Cross Ref link Pubmed link
• 185  Cho SH, Strickland I, Tomkinson A, Fehringer AP, Gelfand EW, Leung DY. Preferential binding of Staphylococcus aureus to skin sites of Th2‐mediated inflammation in a murine model. J Invest Dermatol 2001;116(5):658–63. Cross Ref link Pubmed link
• 186  Cho SH, Strickland I, Boguniewicz M, Leung DY. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol 2001;108(2):269–74. Cross Ref link Pubmed link
• 187  Rebane A, Zimmermann M, Aab A, et al. Mechanisms of IFN‐gamma‐induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. J Allergy Clin Immunol 2012;129(5):1297–306. Cross Ref link Pubmed link
• 188  Gittler JK, Shemer A, Suarez‐Farinas M, et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 2012;130(6):1344–54. Cross Ref link Pubmed link
• 189  Nograles KE, Zaba LC, Shemer A, et al. IL‐22‐producing “T22” T cells account for upregulated IL‐22 in atopic dermatitis despite reduced IL‐17‐producing TH17 T cells. J Allergy Clin Immunol 2009;123(6):1244–52 e2. Cross Ref link Pubmed link
• 190  Fujita H. The role of IL‐22 and Th22 cells in human skin diseases. J Dermatol Sci 2013;72(1):3–8. Cross Ref link Pubmed link
• 191  Gutowska‐Owsiak D, Schaupp AL, Salimi M, Taylor S, Ogg GS. Interleukin‐22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes. Br J Dermatol 2011;165(3):492–8. Cross Ref link Pubmed link
• 192  Wollenberg A, Kraft S, Hanau D, Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 1996;106(3):446–53. Cross Ref link Pubmed link
• 193  Novak N, Kraft S, Bieber T. Unraveling the mission of FcepsilonRI on antigen‐presenting cells. J Allergy Clin Immunol 2003;111(1):38–44. Cross Ref link Pubmed link
• 194  Wilson SR, The L, Batia LM, et al. The epithelial cell‐derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 2013;155(2):285–95. Cross Ref link Pubmed link
• 195  Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006;203(2):269–73. Cross Ref link Pubmed link
• 196  Ma CS, Chew GY, Simpson N, et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 2008;205(7):1551–7. Cross Ref link Pubmed link
• 197  Eyerich K, Pennino D, Scarponi C, et al. IL‐17 in atopic eczema: linking allergen‐specific adaptive and microbial‐triggered innate immune response. J Allergy Clin Immunol 2009;123(1):59–66 e4. Cross Ref link Pubmed link
• 198  Fischer‐Stabauer M, Boehner A, Eyerich S, et al. Differential in situ expression of IL‐17 in skin diseases. Eur J Dermatol 2012;22(6):781–4. Pubmed link
• 199  Gutowska‐Owsiak D, Schaupp AL, Salimi M, et al. IL‐17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion. Exp Dermatol 2012;21(2):104–10. Cross Ref link Pubmed link
• 200  Ma L, Xue HB, Guan XH, et al. The imbalance of Th17 cells and CD4 CD25 Foxp3 Treg cells in patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2014 Aug;28(8):1079–86. Cross Ref link Pubmed link
• 201  Simon D, Aeberhard C, Erdemoglu Y, Simon HU. Th17 cells and tissue remodeling in atopic and contact dermatitis. Allergy 2014;69(1):125–31. Cross Ref link Pubmed link
• 202  Sonkoly E, Muller A, Lauerma AI, et al. IL‐31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006;117(2):411–17. Cross Ref link Pubmed link
• 203  Cornelissen C, Marquardt Y, Czaja K, et al. IL‐31 regulates differentiation and filaggrin expression in human organotypic skin models. J Allergy Clin Immunol 2012;129(2):426–33, 33 e1–8. Cross Ref link Pubmed link
• 204  Guttman‐Yassky E, Lowes MA, Fuentes‐Duculan J, et al. Low expression of the IL‐23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol 2008;181(10):7420–7. Cross Ref link Pubmed link
• 205  Verhagen J, Akdis M, Traidl‐Hoffmann C, et al. Absence of T‐regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 2006;117(1):176–83. Cross Ref link Pubmed link
• 206  Bacchetta R, Passerini L, Gambineri E, et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006;116(6):1713–22. Cross Ref link Pubmed link
• 207  Jutel M, Akdis M, Budak F, et al. IL‐10 and TGF‐beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003;33(5):1205–14. Cross Ref link Pubmed link
• 208  Bellinghausen I, Konig B, Bottcher I, Knop J, Saloga J. Regulatory activity of human CD4 CD25 T cells depends on allergen concentration, type of allergen and atopy status of the donor. Immunology 2005;116(1):103–11. Cross Ref link Pubmed link
• 209  Ling EM, Smith T, Nguyen XD, et al. Relation of CD4+CD25+ regulatory T‐cell suppression of allergen‐driven T‐cell activation to atopic status and expression of allergic disease. Lancet 2004;363(9409):608–15. Cross Ref link Pubmed link
• 210  Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen‐responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004;199(12):1679–88. Cross Ref link Pubmed link
• 211  Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pita O, Girolomoni G. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 2003;171(11):5760–8. Cross Ref link Pubmed link
• 212  Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102(1):98–106. Cross Ref link Pubmed link
• 213  Karagiannidis C, Akdis M, Holopainen P, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004;114(6):1425–33. Cross Ref link Pubmed link
• 214  Peek EJ, Richards DF, Faith A, et al. Interleukin‐10‐secreting “regulatory” T cells induced by glucocorticoids and beta2‐agonists. Am J Respir Cell Mol Biol 2005;33(1):105–11. Cross Ref link Pubmed link
• 215  Ou LS, Goleva E, Hall C, Leung DY. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 2004;113(4):756–63. Cross Ref link Pubmed link
• 216  Loser K, Mehling A, Loeser S, et al. Epidermal RANKL controls regulatory T‐cell numbers via activation of dendritic cells. Nat Med 2006;12(12):1372–9. Cross Ref link Pubmed link
• 217  Vukmanovic‐Stejic M, McQuaid A, Birch KE, et al. Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T‐cell proliferation in patients with atopic dermatitis. Br J Dermatol 2005;153(4):750–7. Cross Ref link Pubmed link
• 218  Oh SH, Park CO, Wu WH, et al. Corticotropin‐releasing hormone downregulates IL‐10 production by adaptive forkhead box protein 3‐negative regulatory T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2012;129(1):151–9 e1–6. Cross Ref link Pubmed link
• 219  Vasiadi M, Therianou A, Sideri K, et al. Increased serum CRH levels with decreased skin CRHR‐1 gene expression in psoriasis and atopic dermatitis. J Allergy Clin Immunol 2012;129(5):1410–13. Cross Ref link Pubmed link
• 220  Katsuta M, Takigawa Y, Kimishima M, Inaoka M, Takahashi R, Shiohara T. NK cells and gamma delta+ T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis. J Immunol 2006;176(12):7736–44. Cross Ref link Pubmed link
• 221  Salimi M, Barlow JL, Saunders SP, et al. A role for IL‐25 and IL‐33‐driven type‐2 innate lymphoid cells in atopic dermatitis. J Exp Med 2013;210(13):2939–50. Cross Ref link Pubmed link
• 222  Carlsten C, Dimich‐Ward H, Ferguson A, et al. Atopic dermatitis in a high‐risk cohort: natural history, associated allergic outcomes, and risk factors. Ann Allergy Asthma Immunol 2013;110(1):24–8. Cross Ref link Pubmed link
• 223  von Kobyletzki LB, Bornehag CG, Hasselgren M, et al. Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort. BMC Dermatol 2012;12:11. Cross Ref link Pubmed link
• 224  Saunes M, Oien T, Dotterud CK, et al. Early eczema and the risk of childhood asthma: a prospective, population‐based study. BMC Pediatr 2012;12:168. Cross Ref link Pubmed link
• 225  Lowe AJ, Carlin JB, Bennett CM, et al. Do boys do the atopic march while girls dawdle? J Allergy Clin Immunol 2008;121(5):1190–5. Cross Ref link Pubmed link
• 226  Arshad SH, Kurukulaaratchy RJ, Fenn M, Matthews S. Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age. Chest 2005;127(2):502–8. Cross Ref link Pubmed link
• 227  Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332(3):133–8. Cross Ref link Pubmed link
• 228  Burgess JA, Dharmage SC, Byrnes GB, et al. Childhood eczema and asthma incidence and persistence: a cohort study from childhood to middle age. J Allergy Clin Immunol 2008;122(2):280–5. Cross Ref link Pubmed link
• 229  van der Hulst AE, Klip H, Brand PL. Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol 2007;120(3):565–9. Cross Ref link Pubmed link
• 230  Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population‐based study. Lancet 2008;372(9643):1049–57. Cross Ref link Pubmed link
• 231  Leynaert B, Neukirch C, Kony S, et al. Association between asthma and rhinitis according to atopic sensitization in a population‐based study. J Allergy Clin Immunol 2004;113(1):86–93. Cross Ref link Pubmed link
• 232  Burgess JA, Walters EH, Byrnes GB, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol 2007;120(4):863–9. Cross Ref link Pubmed link
• 233  Belgrave DC, Granell R, Simpson A, et al. Developmental profiles of eczema, wheeze, and rhinitis: two population‐based birth cohort studies. PLOS Med 2014;11(10):e1001748. Cross Ref link Pubmed link
• 234  Illi S, von Mutius E, Lau S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004;113(5):925–31. Cross Ref link Pubmed link
• 235  Hopper JL, Bui QM, Erbas B, et al. Does eczema in infancy cause hay fever, asthma, or both in childhood? Insights from a novel regression model of sibling data. J Allergy Clin Immunol 2012;130(5):1117–22 e1. Cross Ref link Pubmed link
• 236  Dharmage SC, Lowe AJ, Matheson MC, Burgess JA, Allen KJ, Abramson MJ. Atopic dermatitis and the atopic march revisited. Allergy 2014 Jan;69(1):17–27. Cross Ref link Pubmed link
• 237  Lowe AJ, Tang ML, Dharmage SC, et al. A phase I study of daily treatment with a ceramide‐dominant triple lipid mixture commencing in neonates. BMC Dermatol 2012;12:3. Cross Ref link Pubmed link
• 238  Simpson EL, Berry TM, Brown PA, Hanifin JM. A pilot study of emollient therapy for the primary prevention of atopic dermatitis. J Am Acad Dermatol 2010;63(4):587–93. Cross Ref link Pubmed link
• 239  Simpson EL, Chalmers RJ, Hanifin JM, et al. Barrier enhancement for eczema prevention‐ the BEEP feasibility study. J Invest Dermatol 2012;132 Suppl. 1:S90.
• 240  Fahy JV, Cockcroft DW, Boulet LP, et al. Effect of aerosolized anti‐IgE (E25) on airway responses to inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med 1999;160(3):1023–7. Cross Ref link Pubmed link
• 241  Ong YE, Menzies‐Gow A, Barkans J, et al. Anti‐IgE (omalizumab) inhibits late‐phase reactions and inflammatory cells after repeat skin allergen challenge. J Allergy Clin Immunol 2005;116(3):558–64. Cross Ref link Pubmed link
• 242  Fallon PG, Sasaki T, Sandilands A, et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009;41(5):602–8. Cross Ref link Pubmed link
• 243  Hougaard MG, Johansen JD, Linneberg A, et al. Skin prick test reactivity to aeroallergens by filaggrin mutation status. J Eur Acad Dermatol Venereol 2014 Feb;28(2):238–41. Cross Ref link Pubmed link
• 244  Landeck L, Visser M, Skudlik C, Brans R, Kezic S, John SM. No remarkable differences in rates of sensitization to common type I and IV allergens between FLG loss‐of‐function mutation carriers and wild‐type subjects. Contact Dermatitis 2014 Jan;70(1):27–34. Cross Ref link Pubmed link
• 245  Dhingra N, Gulati N, Guttman‐Yassky E. Mechanisms of contact sensitization offer insights into the role of barrier defects vs. intrinsic immune abnormalities as drivers of atopic dermatitis. J Invest Dermatol 2013;133(10):2311–14. Cross Ref link Pubmed link
• 246  Scheynius A, Johansson C, Buentke E, Zargari A, Linder MT. Atopic eczema/dermatitis syndrome and Malassezia. Int Arch Allergy Immunol 2002;127(3):161–9. Cross Ref link Pubmed link
• 247  Tang TS, Bieber T, Williams HC. Does “autoreactivity” play a role in atopic dermatitis? J Allergy Clin Immunol 2012;129(5):1209–15 e2. Cross Ref link Pubmed link
• 248  Novak N, Allam JP, Bieber T. Allergic hyperreactivity to microbial components: a trigger factor of “intrinsic” atopic dermatitis? J Allergy Clin Immunol 2003;112(1):215–16. Cross Ref link Pubmed link
• 249  Nordvall SL, Lindgren L, Johansson SG, Johansson S, Petrini B. IgE antibodies to Pityrosporum orbiculare and Staphylococcus aureus in patients with very high serum total IgE. Clin Exp Allergy 1992;22(8):756–61. Cross Ref link Pubmed link
• 250  McFadden JP, Noble WC, Camp RD. Superantigenic exotoxin‐secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993;128(6):631–2. Cross Ref link Pubmed link
• 251  Hofer MF, Lester MR, Schlievert PM, Leung DY. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin‐1 in peripheral blood mononuclear cells from patients with atopic dermatitis. Clin Exp Allergy 1995;25(12):1218–27. Cross Ref link Pubmed link
• 252  Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347(15):1151–60. Cross Ref link Pubmed link
• 253  Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives [see comments]. Science 1990;248(4956):705–11. Comment in: Science 1990 May 11;248(4956):685–6. Cross Ref link Pubmed link
• 254  Jeffry J, Kim S, Chen ZF. Itch signaling in the nervous system. Physiology (Bethesda) 2011;26(4):286–92. Cross Ref link Pubmed link
• 255  Steinhoff M, Neisius U, Ikoma A, et al. Proteinase‐activated receptor‐2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003;23(15):6176–80. Pubmed link
• 256  Diepgen TL. Long‐term treatment with cetirizine of infants with atopic dermatitis: a multi‐country, double‐blind, randomized, placebo‐controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol 2002;13(4):278–86. Cross Ref link Pubmed link
• 257  Steinhoff M, Steinhoff A, Homey B, Luger TA, Schneider SW. Role of vasculature in atopic dermatitis. J Allergy Clin Immunol 2006;118(1):190–7. Cross Ref link Pubmed link
• 258  Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti‐IgE) for asthma in inner‐city children. N Engl J Med 2011;364(11):1005–15. Cross Ref link Pubmed link
• 259  Kim DH, Park KY, Kim BJ, Kim MN, Mun SK. Anti‐immunoglobulin E in the treatment of refractory atopic dermatitis. Clin Exp Dermatol 2013;38(5):496–500. Cross Ref link Pubmed link
• 260  Fernandez‐Anton Martinez MC, Leis‐Dosil V, Alfageme‐Roldan F, Paravisini A, Sanchez‐Ramon S, Suarez Fernandez R. Omalizumab for the treatment of atopic dermatitis. Actas Dermosifiliogr 2012;103(7):624–8. Cross Ref link Pubmed link
• 261  Velling P, Skowasch D, Pabst S, Jansen E, Tuleta I, Grohe C. Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow‐up of omalizumab therapy. Eur J Med Res 2011;16(9):407–10. Cross Ref link Pubmed link
• 262  Ramirez del Pozo ME, Contreras Contreras E, Lopez Tiro J, Gomez Vera J. Omalizumab (an anti‐IgE antibody) in the treatment of severe atopic eczema. J Investig Allergol Clin Immunol 2011;21(5):416–17. Pubmed link
• 263  Sheinkopf LE, Rafi AW, Do LT, Katz RM, Klaustermeyer WB. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study. Allergy Asthma Proc 2008;29(5):530–7. Cross Ref link Pubmed link
• 264  Andres C, Belloni B, Mempel M, Ring J. Omalizumab for patients with severe and therapy‐refractory atopic eczema? Curr Allergy Asthma Rep 2008;8(3):179–80. Cross Ref link Pubmed link
• 265  Belloni B, Ziai M, Lim A, et al. Low‐dose anti‐IgE therapy in patients with atopic eczema with high serum IgE levels. J Allergy Clin Immunol 2007;120(5):1223–5. Cross Ref link Pubmed link
• 266  Vigo PG, Girgis KR, Pfuetze BL, Critchlow ME, Fisher J, Hussain I. Efficacy of anti‐IgE therapy in patients with atopic dermatitis. J Am Acad Dermatol 2006;55(1):168–70. Cross Ref link Pubmed link
• 267  Krathen RA, Hsu S. Failure of omalizumab for treatment of severe adult atopic dermatitis. J Am Acad Dermatol 2005;53(2):338–40. Cross Ref link Pubmed link
• 268  Iyengar SR, Hoyte EG, Loza A, et al. Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo‐controlled clinical trial. Int Arch Allergy Immunol 2013;162(1):89–93. Cross Ref link Pubmed link
• 269  Heil PM, Maurer D, Klein B, Hultsch T, Stingl G. Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course – a randomized, placebo‐controlled and double blind pilot study. J Dtsch Dermatol Ges 2010;8(12):990–8. Pubmed link
• 270  Flohr C. The role of allergic sensitisation in childhood eczema: an epidemiologist's perspective. Allergol Immunopathol (Madr) 2009;37(2):89–92. Cross Ref link Pubmed link
• 271  Flohr C, Weiland SK, Weinmayr G, et al. The role of atopic sensitization in flexural eczema: findings from the International Study of Asthma and Allergies in Childhood Phase Two. J Allergy Clin Immunol 2008;121(1):141–7 e4. Cross Ref link Pubmed link
• 272  Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol 2006;118(1):209–13. Cross Ref link Pubmed link
• 273  Kelly LA, Erwin EA, Platts‐Mills TA. The indoor air and asthma: the role of cat allergens. Curr Opin Pulm Med 2012;18(1):29–34. Cross Ref link Pubmed link
• 274  Werfel T, Erdmann S, Fuchs T, et al. Approach to suspected food allergy in atopic dermatitis. Guideline of the Task Force on Food Allergy of the German Society of Allergology and Clinical Immunology (DGAKI) and the Medical Association of German Allergologists (ADA) and the German Society of Pediatric Allergology (GPA). J Dtsch Dermatol Ges 2009;7(3):265–71. Pubmed link
• 275  Bock SA, Atkins FM. Patterns of food hypersensitivity during sixteen years of double‐blind, placebo‐controlled food challenges. J Pediatr 1990;117(4):561–7. Cross Ref link Pubmed link
• 276  Sampson HA, Albergo R. Comparison of results of skin tests, RAST, and double‐blind, placebo‐controlled food challenges in children with atopic dermatitis. J Allergy Clin Immunol 1984;74(1):26–33. Cross Ref link Pubmed link
• 277  Alexander DD, Cabana MD. Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta‐analysis. J Pediatr Gastroenterol Nutr 2010;50(4):422–30. Pubmed link
• 278  Szajewska H, Horvath A. Meta‐analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Curr Med Res Opin 2010;26(2):423–37. Cross Ref link Pubmed link
• 279  Grimshaw KE, Allen K, Edwards CA, et al. Infant feeding and allergy prevention: a review of current knowledge and recommendations. A EuroPrevall state of the art paper. Allergy 2009;64(10):1407–16. Cross Ref link Pubmed link
• 280  Bath‐Hextall F, Delamere FM, Williams HC. Dietary exclusions for established atopic eczema. Cochrane Database Syst Rev 2008(1):CD005203. Pubmed link
• 281  Lever R, MacDonald C, Waugh P, Aitchison T. Randomised controlled trial of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs. Pediatr Allergy Immunol 1998;9(1):13–19. Cross Ref link Pubmed link
• 282  Monti G, Muratore MC, Peltran A, et al. High incidence of adverse reactions to egg challenge on first known exposure in young atopic dermatitis children: predictive value of skin prick test and radioallergosorbent test to egg proteins. Clin Exp Allergy 2002;32(10):1515–19. Cross Ref link Pubmed link
• 283  Clark AT, Skypala I, Leech SC, et al. British Society for Allergy and Clinical Immunology guidelines for the management of egg allergy. Clin Exp Allergy 2010;40(8):1116–29. Cross Ref link Pubmed link
• 284  Ring J, Kunz B, Bieber T, Vieluf D, Przybilla B. The “atopy patch test” with aeroallergens in atopic eczema [Abstract]. J Allergy Clin Immunol 1989;83:195.
• 285  Munro CS, Higgins EM, Marks JM, Daly BM, Friedmann PS, Shuster S. Cyclosporin A in atopic dermatitis: therapeutic response is dissociated from effects on allergic reactions. Br J Dermatol 1991;124(1):43–8. Cross Ref link Pubmed link
• 286  Friedmann PS, Tan BB, Musaba E, Strickland I. Pathogenesis and management of atopic dermatitis. Clin Exp Allergy 1995;25(9):799–806. Cross Ref link Pubmed link
• 287  van Voorst Vader PC, Lier JG, Woest TE, Coenraads PJ, Nater JP. Patch tests with house dust mite antigens in atopic dermatitis patients: methodological problems. Acta Derm Venereol 1991;71(4):301–5. Pubmed link
• 288  Darsow U, Laifaoui J, Kerschenlohr K, et al. The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy 2004;59(12):1318–25. Cross Ref link Pubmed link
• 289  Mehl A, Rolinck‐Werninghaus C, Staden U, et al. The atopy patch test in the diagnostic workup of suspected food‐related symptoms in children. J Allergy Clin Immunol 2006;118(4):923–9. Cross Ref link Pubmed link
• 290  Baker BS. The role of microorganisms in atopic dermatitis. Clin Exp Immunol 2006;144(1):1–9. Cross Ref link Pubmed link
• 291  Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 2003;112(6):1195–202. Cross Ref link Pubmed link
• 292  Broccardo CJ, Mahaffey S, Schwarz J, et al. Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization. J Allergy Clin Immunol 2011;127(1):186–93, 93 e1–11. Cross Ref link Pubmed link
• 293  Bruch‐Gerharz D, Fehsel K, Suschek C, et al. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med 1996;184(5):2007–12. Cross Ref link Pubmed link
• 294  Rieg S, Steffen H, Seeber S, et al. Deficiency of dermcidin‐derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 2005;174(12):8003–10. Cross Ref link Pubmed link
• 295  Imayama S, Shimozono Y, Hoashi M, et al. Reduced secretion of IgA to skin surface of patients with atopic dermatitis. J Allergy Clin Immunol 1994;94(2 Pt 1):195–200. Cross Ref link Pubmed link
• 296  Toshitani A, Imayama S, Shimozono Y, Yoshinaga T, Furue M, Hori Y. Reduced amount of secretory component of IgA secretion in tears of patients with atopic dermatitis. J Dermatol Sci 1999;19(2):134–8. Cross Ref link Pubmed link
• 297  Guzik TJ, Bzowska M, Kasprowicz A, et al. Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin Exp Allergy 2005;35(4):448–55. Cross Ref link Pubmed link
• 298  Zollner TM, Munk ME, Keller T, et al. The superantigen exfoliative toxin induces cutaneous lymphocyte‐associated antigen expression in peripheral human T lymphocytes. Immunol Lett 1996;49(1–2):111–16. Cross Ref link Pubmed link
• 299  Zollner TM, Wichelhaus TA, Hartung A, et al. Colonization with superantigen‐producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy 2000;30(7):994–1000. Cross Ref link Pubmed link
• 300  Bunikowski R, Mielke ME, Skarabis H, et al. Evidence for a disease‐promoting effect of Staphylococcus aureus‐derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000;105(4):814–19. Cross Ref link Pubmed link
• 301  Langer K, Breuer K, Kapp A, Werfel T. Staphylococcus aureus‐derived enterotoxins enhance house dust mite‐induced patch test reactions in atopic dermatitis. Exp Dermatol 2007;16(2):124–9. Cross Ref link Pubmed link
• 302  Li LB, Goleva E, Hall CF, Ou LS, Leung DY. Superantigen‐induced corticosteroid resistance of human T cells occurs through activation of the mitogen‐activated protein kinase kinase/extracellular signal‐regulated kinase (MEK‐ERK) pathway. J Allergy Clin Immunol 2004;114(5):1059–69. Cross Ref link Pubmed link
• 303  Gao PS, Rafaels NM, Mu D, et al. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol 2010;125(6):1403–7 e4. Cross Ref link Pubmed link
• 304  Gao PS, Leung DY, Rafaels NM, et al. Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum. J Invest Dermatol 2012;132(3 Pt 1):650–7. Cross Ref link Pubmed link
• 305  Leung DY, Gao PS, Grigoryev DN, et al. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN‐gamma response. J Allergy Clin Immunol 2011;127(4):965–73 e1–5. Cross Ref link Pubmed link
• 306  Bin L, Edwards MG, Heiser R, et al. Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum. J Allergy Clin Immunol 2014;134(4):848–55. Cross Ref link Pubmed link
• 307  Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974;90(5):525–30. Cross Ref link Pubmed link
• 308  Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012;22(5):850–9. Cross Ref link Pubmed link
• 309  Mossabeb R, Seiberler S, Mittermann I, et al. Characterization of a novel isoform of alpha‐nascent polypeptide‐associated complex as IgE‐defined autoantigen. J Invest Dermatol 2002;119(4):820–9. Cross Ref link Pubmed link
• 310  Valenta R, Seiberler S, Natter S, et al. Autoallergy: a pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol 2000;105(3):432–7. Cross Ref link Pubmed link
• 311  Lobitz WC Jr, Campbell CJ. Physiologic studies in atopic dermatitis (disseminated neurodermatitis). I. The local cutaneous response to intradermally injected acetylcholine and epinephrine. AMA Arch Derm Syphilol 1953;67(6):575–89. Cross Ref link Pubmed link
• 312  Hornstein OP, Boissevain F, Wittmann H. Non‐invasive measurement of the vascular dynamics of dermographism – comparative study in atopic and non‐atopic subjects. J Dermatol 1991;18(2):79–85. Cross Ref link Pubmed link
• 313  Aizawa H, Tagami H. Inability to produce white dermographism in the early stage of infantile eczema. Pediatr Dermatol 1989;6(1):6–9. Cross Ref link Pubmed link
• 314  Hanifin JM, Chan SC, Cheng JB, et al. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti‐inflammatory effects in atopic dermatitis. J Invest Dermatol 1996;107(1):51–6. Cross Ref link Pubmed link
• 315  Grewe SR, Chan SC, Hanifin JM. Elevated leukocyte cyclic AMP‐phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP‐agonist hyporesponsiveness. J Allergy Clin Immunol 1982;70(6):452–7. Cross Ref link Pubmed link
• 316  Chan SC, Reifsnyder D, Beavo JA, Hanifin JM. Immunochemical characterization of the distinct monocyte cyclic AMP‐phosphodiesterase from patients with atopic dermatitis. J Allergy Clin Immunol 1993;91(6):1179–88. Cross Ref link Pubmed link
• 317  Hanifin JM, Chan SC. Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis. J Invest Dermatol 1995;105(1 Suppl.):84S–8S. Cross Ref link Pubmed link
• 318  Souness JE, Aldous D, Sargent C. Immunosuppressive and anti‐inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology 2000;47(2–3):127–62. Cross Ref link Pubmed link
• 319  Griffiths CE, Van Leent EJ, Gilbert M, Traulsen J. Randomized comparison of the type 4 phosphodiesterase inhibitor cipamfylline cream, cream vehicle and hydrocortisone 17‐butyrate cream for the treatment of atopic dermatitis. Br J Dermatol 2002;147(2):299–307. Cross Ref link Pubmed link
• 320  Papp K, Cather JC, Rosoph L, et al. Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial. Lancet 2012;380(9843):738–46. Cross Ref link Pubmed link
• 321  Samrao A, Berry TM, Goreshi R, Simpson EL. A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults. Arch Dermatol 2013;148(8):890–7.
• 322  Kim CH, Choi YS, Cheong KA, Lee AY. Mechanism underlying the effect of combined therapy using glucosamine and low‐dose cyclosporine A on the development of atopic dermatitis‐like skin lesions in NC/Nga mice. Int Immunopharmacol 2013;15(2):424–32. Cross Ref link Pubmed link
• 323  Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF. Cellular basis of itch sensation. Science 2009;325(5947):1531–4. Cross Ref link Pubmed link
• 324  Pfab F, Valet M, Sprenger T, et al. Temperature modulated histamine‐itch in lesional and nonlesional skin in atopic eczema ‐ a combined psychophysical and neuroimaging study. Allergy 2010;65(1):84–94. Cross Ref link Pubmed link
• 325  Pincelli C, Fantini F, Romualdi P, Lesa G, Giannetti A. Skin levels of vasoactive intestinal polypeptide in atopic dermatitis. Arch Dermatol Res 1991;283(4):230–2. Cross Ref link Pubmed link
• 326  Giannetti A, Fantini F, Cimitan A, Pincelli C. Vasoactive intestinal polypeptide and substance P in the pathogenesis of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:90–2. Pubmed link
• 327  Anand P, Springall DR, Blank MA, Sellu D, Polak JM, Bloom SR. Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Br J Dermatol 1991;124(6):547–9. Cross Ref link Pubmed link
• 328  Fantini F, Pincelli C, Romualdi P, Donatini A, Giannetti A. Substance P levels are decreased in lesional skin of atopic dermatitis. Exp Dermatol 1992;1(3):127–8. Cross Ref link Pubmed link
• 329  Roggenkamp D, Kopnick S, Stab F, Wenck H, Schmelz M, Neufang G. Epidermal nerve fibers modulate keratinocyte growth via neuropeptide signaling in an innervated skin model. J Invest Dermatol 2013;133(6):1620–8. Cross Ref link Pubmed link
• 330  Stander S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001;44(3):471–8. Cross Ref link Pubmed link
• 331  Grando SA, Kist DA, Qi M, Dahl MV. Human keratinocytes synthesize, secrete, and degrade acetylcholine. J Invest Dermatol 1993;101(1):32–6. Cross Ref link Pubmed link
• 332  Heyer G, Vogelgsang M, Hornstein OP. Acetylcholine is an inducer of itching in patients with atopic eczema. J Dermatol 1997;24(10):621–5. Cross Ref link Pubmed link
• 333  Dillon SR, Sprecher C, Hammond A, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004;5(7):752–60. Cross Ref link Pubmed link
• 334  Takaoka A, Arai I, Sugimoto M, Yamaguchi A, Tanaka M, Nakaike S. Expression of IL‐31 gene transcripts in NC/Nga mice with atopic dermatitis. Eur J Pharmacol 2005;516(2):180–1. Cross Ref link Pubmed link
• 335  Takaoka A, Arai I, Sugimoto M, et al. Involvement of IL‐31 on scratching behavior in NC/Nga mice with atopic‐like dermatitis. Exp Dermatol 2006;15(3):161–7. Cross Ref link Pubmed link
• 336  Bilsborough J, Leung DY, Maurer M, et al. IL‐31 is associated with cutaneous lymphocyte antigen‐positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2006;117(2):418–25. Cross Ref link Pubmed link
• 337  Stott B, Lavender P, Lehmann S, Pennino D, Durham S, Schmidt‐Weber CB. Human IL‐31 is induced by IL‐4 and promotes TH2‐driven inflammation. J Allergy Clin Immunol 2013;132(2):446–54 e5. Cross Ref link Pubmed link
• 338  Raap U, Weissmantel S, Gehring M, Eisenberg AM, Kapp A, Folster‐Holst R. IL‐31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr Allergy Immunol 2012;23(3):285–8. Cross Ref link Pubmed link
• 339  Ostlere LS, Cowen T, Rustin MH. Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol 1995;20(6):462–7. Cross Ref link Pubmed link
• 340  Kiistala R, Kiistala U, Parkkinen MU. Local cholinergic sweat stimulation in atopic dermatitis. An evaporimetric study. Acta Derm Venereol 1991;71(3):219–23. Pubmed link
• 341  Kiistala R. Cholinergic and adrenergic sweating in atopic dermatitis. Acta Derm Venereol 1992;72(2):106–8. Pubmed link
• 342  Kato F, Saga K, Morimoto Y, Kaneko R. Pilocarpine‐induced cholinergic sweat secretion compared with emotional sweat secretion in atopic dermatitis. Br J Dermatol 1999;140(6):1110–13. Cross Ref link Pubmed link
• 343  Eishi K, Lee JB, Bae SJ, Takenaka M, Katayama I. Impaired sweating function in adult atopic dermatitis: results of the quantitative sudomotor axon reflex test. Br J Dermatol 2002;147(4):683–8. Cross Ref link Pubmed link
• 344  Kiistala R. Adrenaline‐induced local sweating and vasoconstrictive responses in atopic skin. Br J Dermatol 1992;126(3):246–9. Cross Ref link Pubmed link
• 345  Parkkinen MU, Kiistala R, Kiistala U. Sweating response to moderate thermal stress in atopic dermatitis. Br J Dermatol 1992;126(4):346–50. Cross Ref link Pubmed link
• 346  Bothorel B, Heller A, Grosshans E, Candas V. Thermal and sweating responses in normal and atopic subjects under internal and moderate external heat stress. Arch Dermatol Res 1992;284(3):135–40. Cross Ref link Pubmed link
• 347  Hide M, Tanaka T, Yamamura Y, Koro O, Yamamoto S. IgE‐mediated hypersensitivity against human sweat antigen in patients with atopic dermatitis. Acta Derm Venereol 2002;82(5):335–40. Cross Ref link Pubmed link
• 348  Tanaka A, Tanaka T, Suzuki H, Ishii K, Kameyoshi Y, Hide M. Semi‐purification of the immunoglobulin E‐sweat antigen acting on mast cells and basophils in atopic dermatitis. Exp Dermatol 2006;15(4):283–90. Cross Ref link Pubmed link
• 349  Takahagi S, Tanaka T, Ishii K, et al. Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis. Br J Dermatol 2009;160(2):426–8. Cross Ref link Pubmed link
• 350  Buske‐Kirschbaum A, Geiben A, Wermke C, Pirke KM, Hellhammer D. Preliminary evidence for Herpes labialis recurrence following experimentally induced disgust. Psychother Psychosom 2001;70(2):86–91. Cross Ref link Pubmed link
• 351  Arnetz BB, Fjellner B, Eneroth P, Kallner A. Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med 1985;47(6):528–41. Cross Ref link Pubmed link
• 352  Buske‐Kirschbaum A, Jobst S, Wustmans A, Kirschbaum C, Rauh W, Hellhammer D. Attenuated free cortisol response to psychosocial stress in children with atopic dermatitis. Psychosom Med 1997;59(4):419–26. Cross Ref link Pubmed link
• 353  Kemmett D, Tidman MJ. The influence of the menstrual cycle and pregnancy on atopic dermatitis. Br J Dermatol 1991;125(1):59–61. Cross Ref link Pubmed link
• 354  Rohleder N, Schommer NC, Hellhammer DH, Engel R, Kirschbaum C. Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosom Med 2001;63(6):966–72. Cross Ref link Pubmed link
• 355  Novak N, Bieber T, Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003;112(6 Suppl.):S128–39. Cross Ref link Pubmed link
• 356  Brown SJ, Relton CL, Liao H, et al. Filaggrin haploinsufficiency is highly penetrant and is associated with increased severity of eczema: further delineation of the skin phenotype in a prospective epidemiological study of 792 school children. Br J Dermatol 2009;161(4):884–9. Cross Ref link Pubmed link
• 357  Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy 2014;69(1):3–16. Cross Ref link Pubmed link
• 358  Bath‐Hextall FJ, Jenkinson C, Humphreys R, Williams HC. Dietary supplements for established atopic eczema. Cochrane Database Syst Rev 2012 Feb 15;2:CD005205. Pubmed link